Hematologist
CION Cancer Clinics
Will I get a placebo in a blood cancer trial? | CION Cancer Clinics
Almost never instead of treatment. When a blood cancer has a standard treatment that works, trials give that treatment to everyone and add either the new medicine or a look-alike placebo on top. Placebos alone appear mainly where careful watching is already the usual care. This page explains the designs you may meet, the words on the consent form, and what to ask before you agree. At CION Cancer Clinics, our haematology team supports patients and families through treatment, cost questions and life at home.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Will you be given a placebo instead of treatment?
- Where might a placebo appear in a blood cancer trial?
- How are you placed in a group, and who knows which one?
- What do families believe about placebos, and what is true?
- Which words on the consent form matter most?
- What should you ask the trial doctor about the placebo?
- Common questions about placebos in blood cancer trials
The short answer
Will you be given a placebo instead of treatment?
Almost never on its own. When a blood cancer already has a standard treatment that works, an ethical trial does not replace that treatment with a dummy pill. If a placebo is used at all, it is usually added on top of the standard treatment that everyone in the trial receives.
What a placebo actually is
A placebo is a tablet, capsule or drip that looks exactly like the new medicine but contains nothing active. It is there so that neither you nor the doctors can guess which group you are in. That keeps the results honest. People often feel better or worse simply because they know they are on something new, and a placebo lets the trial separate that effect from the effect of the medicine.
Why families fear it
The fear is that a parent with leukaemia or lymphoma will be handed a sugar pill while the cancer grows. In a properly run trial that is not how it works. The ethics committee that approves the trial checks that nobody is denied a treatment they would otherwise have received.
What this page cannot tell you
Every trial is designed differently. Only the consent form and the trial doctor can tell you whether a placebo is used in the particular trial you have been offered, and what it would mean for you.
Read the section of the consent form headed "study design" or "treatment groups" first. It says whether a placebo is used.Trial designs
Where might a placebo appear in a blood cancer trial?
There are four common situations. Knowing which one you are in answers most of the worry.
Standard treatment plus new drug or placebo
Everyone gets the usual treatment for their blood cancer. One group also gets the new medicine, the other gets a placebo that looks the same. Nobody goes without proper treatment.
New drug against standard drug
One group gets the treatment already in use, the other gets the new one. There is no placebo at all. Many leukaemia, lymphoma and myeloma trials look like this.
After treatment has finished
Some trials test whether a medicine taken after successful treatment keeps the disease away for longer. Here the comparison group may get a placebo, because the usual care at that stage is regular check-ups.
Ask about
- How often you will be checked
- What happens if the disease returns
When the usual care is watching
Some slow-growing blood cancers are not treated straight away. A trial may compare an early medicine with a placebo, because careful watching is already the standard approach for those people.
Not sure whether this applies to you?
Ask an oncologistInside the trial
How are you placed in a group, and who knows which one?
You agree to take part
The trial team explains the groups, the placebo if there is one, and what each visit involves. You sign only after your questions are answered, and you can take the form home to discuss with family first.
A computer picks the group
This is called randomisation. It works like a coin toss. Your doctor cannot choose the group for you, which stops anyone steering sicker or healthier people into one arm.
Nobody is told the group
In a blinded trial you do not know whether you are on the medicine or the placebo. In a double-blind trial your doctors do not know either. The record is kept safely by a separate team.
The code can be broken if needed
If you become seriously unwell and the treating doctor needs to know what you are taking, the group can be revealed quickly. Blinding never comes before your safety.
Commonly believed
What do families believe about placebos, and what is true?
"If he gets the placebo, he gets no treatment."
In most blood cancer trials the placebo is given on top of standard treatment. The placebo group still receives the care they would have had outside the trial. The consent form must say this in writing.
"They will keep her on the placebo even if the cancer grows."
Every trial has rules about what happens when the disease progresses. You come off the trial treatment and your doctors choose the next step. Some trials also let people in the placebo group switch to the new medicine later. Ask whether yours does.
"Being in a trial means being used as a test subject."
Trials in India need approval from the national drug regulator and an ethics committee, and must be listed on the national trial registry. You are watched more closely than in routine care, not less.
"Once we sign, we cannot leave."
You can withdraw at any time without giving a reason. Leaving does not affect the care you receive afterwards. Your treating team will help you move back onto standard treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On the consent form
Which words on the consent form matter most?
- Placebo-controlled
- One group receives a dummy medicine so the results can be compared fairly. Check whether it is added to standard treatment.
- Randomised
- Your group is chosen by chance, not by you or your doctor.
- Double-blind
- Neither you nor the trial doctors know which group you are in until the trial ends or the code is broken for safety.
- Arm
- One of the groups in the trial. A two-arm trial has two groups.
- Crossover
- People in one group may later switch to the other treatment, usually when the disease grows.
- Open-label
- Everyone knows which treatment is being given. There is no placebo.
Did you know
Every trial run in India has to be registered with the Clinical Trials Registry of India before the first person joins. You can search it by the trial name or number printed on your consent form.
Before you sign
What should you ask the trial doctor about the placebo?
Ask plainly whether a placebo is used, and if so, what you will be taking alongside it. A good trial team answers this in one sentence. If the answer is unclear, ask again, and ask for it in writing.
Questions worth writing down
Will I still get the standard treatment for my condition? What happens if my blood counts or scans get worse? Can I switch to the new medicine later? Who do I call at night if I feel unwell, and can they break the code? Will joining change which hospital I am treated at?
Who a placebo-controlled trial may not suit
If your disease is moving fast and you need a decision quickly, a trial with a long screening period may not suit you. The same applies if you cannot travel for frequent visits, or if the uncertainty of not knowing your group would cause real distress. Saying no is a reasonable choice.
Getting a second look
CION's haematology team can review your reports and the consent form with you, explain the design in plain language, and discuss whether the trial fits your situation. The team does not decide for you, and it does not choose your group.
Do not stop or change any medicine you are already taking because of a trial offer. Your treating team decides that with you.Questions we are asked
Common questions about placebos in blood cancer trials
Is it ethical to give a cancer patient a placebo?
It is considered ethical only when nobody loses a treatment they would otherwise receive. That is why placebos in blood cancer trials are usually added to standard care, or used where watching is already the usual approach. An ethics committee reviews this before the trial opens, and checks it again while the trial runs.
Can I choose to be in the new medicine group?
No. The group is chosen by chance so the comparison stays fair. If you only want the new medicine, ask whether an open-label trial or an access programme exists for your condition. Those are different routes, and your haematologist can tell you whether either is realistic for you.
Will I be able to tell if I am on the placebo?
Usually not with any certainty. The placebo is made to look, taste and feel the same. Some people guess from side effects, but guesses are often wrong, because the standard treatment causes side effects too. Try not to change how you look after yourself based on a guess.
What happens when the trial ends?
You are usually told which group you were in once the results are analysed. The consent form should say whether people who benefited can keep receiving the medicine afterwards. Ask about this before you join, because the answer differs from trial to trial.
Is a placebo used for children with leukaemia?
Placebo designs are rare in childhood leukaemia trials, because standard treatment is well established. Most children's trials compare ways of giving existing treatment. Parents sign consent, and older children are asked for their agreement too. Ask the trial team to explain the design to your child in words they understand.
Does the placebo group still have tests and check-ups?
Yes. Both groups follow the same visit schedule, blood tests and scans. That is part of keeping the trial blinded. In practice this often means closer monitoring than routine care, which some families find reassuring and others find tiring.
Can I leave if I think I am on the placebo?
Yes. You can withdraw at any time, for any reason, and your care afterwards should not suffer. Talk to the trial doctor first, because leaving suddenly can affect the timing of your next treatment. They will plan a safe handover to standard care with you.
Who checks that the trial is safe while it runs?
An ethics committee reviews the trial before and during it, and many larger trials also have an independent safety board that looks at results early. If one group is clearly doing worse, the trial can be changed or stopped. Serious side effects must be reported to the regulator.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer.Net — Placebos in Cancer Clinical Trials
- Cancer Research UK — Randomised trials
- National Cancer Institute — Clinical trials information for patients and caregivers
- NHS — Clinical trials
- ICMR — Clinical Trials Registry - India
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Clinical Trials in HaematologyThe full guide to trials for blood cancers and disordersFinding a Blood Cancer Trial in IndiaHow to search for trials that fit your diagnosisWithdrawing From a TrialWhat happens if you decide to leaveCosts Covered and Not Covered in a TrialWho pays for what once you join
Talk to us
Offered a trial and unsure what it means?
Bring the consent form and your reports. CION's haematology team will go through the design with you in plain language.